Paloma Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-8,500
Closed -$2.84M 271
2024
Q3
$2.84M Buy
8,500
+6,614
+351% +$2.21M 0.08% 121
2024
Q2
$515K Buy
+1,886
New +$515K 0.01% 387
2022
Q3
Sell
-650
Closed -$322K 399
2022
Q2
$322K Sell
650
-2,437
-79% -$1.21M 0.01% 463
2022
Q1
$1.74M Buy
3,087
+1,685
+120% +$949K 0.05% 143
2021
Q4
$1.06M Buy
+1,402
New +$1.06M 0.02% 526
2021
Q3
Sell
-1,403
Closed -$903K 937
2021
Q2
$903K Buy
1,403
+41
+3% +$26.4K 0.02% 493
2021
Q1
$778K Sell
1,362
-396
-23% -$226K 0.02% 678
2020
Q4
$1.03M Buy
1,758
+1,168
+198% +$681K 0.03% 408
2020
Q3
$304K Sell
590
-10,985
-95% -$5.66M 0.01% 1318
2020
Q2
$5.23M Buy
+11,575
New +$5.23M 0.09% 249
2020
Q1
Sell
-1,297
Closed -$480K 1159
2019
Q4
$480K Buy
1,297
+333
+35% +$123K 0.01% 1154
2019
Q3
$321K Sell
964
-1,144
-54% -$381K 0.01% 1177
2019
Q2
$659K Buy
2,108
+663
+46% +$207K 0.01% 710
2019
Q1
$442K Buy
+1,445
New +$442K 0.01% 834
2018
Q4
Sell
-2,306
Closed -$722K 1025
2018
Q3
$722K Sell
2,306
-6,774
-75% -$2.12M 0.01% 638
2018
Q2
$2.62M Buy
9,080
+6,358
+234% +$1.83M 0.05% 241
2018
Q1
$681K Buy
+2,722
New +$681K 0.01% 763
2017
Q4
Sell
-3,358
Closed -$746K 1278
2017
Q3
$746K Sell
3,358
-5,397
-62% -$1.2M 0.01% 788
2017
Q2
$1.98M Buy
8,755
+1,495
+21% +$338K 0.02% 426
2017
Q1
$1.45M Buy
+7,260
New +$1.45M 0.02% 620
2016
Q2
Sell
-6,801
Closed -$930K 1716
2016
Q1
$930K Buy
+6,801
New +$930K 0.02% 610
2015
Q4
Sell
-10,000
Closed -$1.34M 1364
2015
Q3
$1.34M Buy
10,000
+371
+4% +$49.8K 0.03% 313
2015
Q2
$1.45M Buy
9,629
+5,830
+153% +$878K 0.03% 419
2015
Q1
$514K Sell
3,799
-5,755
-60% -$779K 0.01% 668
2014
Q4
$1.15M Buy
+9,554
New +$1.15M 0.05% 320
2014
Q3
Sell
-2,243
Closed -$269K 933
2014
Q2
$269K Buy
+2,243
New +$269K 0.01% 762
2014
Q1
Sell
-6,259
Closed -$773K 646
2013
Q4
$773K Buy
+6,259
New +$773K 0.04% 456